1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Davis, Ian D
Author:  MacGregor, Duncan

Results 1-8 of 8 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
1Apr-2020Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.Cebon, Jonathan S ; Gore, Martin; Thompson, John F; Davis, Ian D; McArthur, Grant A; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P N; Hersey, Peter; Evans, T R Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G; Corrie, Pippa G; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M; Endo-Munoz, Liliana; Tutuka, Candani S A; Venhaus, Ralph; Old, Lloyd J; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan
2Mar-2017A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantDavis, Ian D; Quirk, Juliet; Morris, Leone; Seddon, Lauren; Tai, Tsin Yee; Whitty, Genevieve; Cavicchiolo, Tina; Ebert, Lisa; Jackson, Heather; Browning, Judy; MacGregor, Duncan; Wittke, Frederick; Winkels, Gregor; Alex, Regina; Miloradovic, Lena; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S 
34-Nov-2010Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.Svobodová, Suzanne; Browning, Judy; MacGregor, Duncan; Pollara, Gabriele; Scolyer, Richard A; Murali, Rajmohan; Thompson, John F; Deb, Siddhartha; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
415-Apr-2008The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.Ebert, Lisa M; Tan, Bee Shin; Browning, Judy; Svobodova, Suzanne; Russell, Sarah E; Kirkpatrick, Naomi; Gedye, Craig; Moss, Denis; Ng, Sweet Ping ; MacGregor, Duncan; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
510-Sep-2006Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.Davis, Ian D; Chen, Qiyuan; Morris, Leone; Quirk, Juliet; Stanley, Maureen; Tavarnesi, Maria L; Parente, Phillip; Cavicchiolo, Tina; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin Yee; MacGregor, Duncan; Browning, Judy; Svobodova, Suzanne; Caron, Dania; Maraskovsky, Eugene; Old, Lloyd J; Chen, Weisan; Cebon, Jonathan S 
61-Aug-2006Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.Lim, Elgene; Browning, Judy; MacGregor, Duncan; Davis, Ian D; Cebon, Jonathan S 
722-Feb-2005Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J
81-Oct-2001Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.Scott, Andrew M ; Lee, Fook-Thean; Hopkins, Wendie; Cebon, Jonathan S ; Wheatley, J M; Liu, Z; Smyth, Fiona E; Murone, Carmel ; Sturrock, S; MacGregor, Duncan; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, Martin W; Davis, Ian D; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, Geoffrey ; Ritter, G; Hoffman, E W; Burgess, Antony W; Old, Lloyd J